SCOPUS 정보 검색 플랫폼

Bone

Volumn 30, Issue 1, 2002, Pages 14-17

Different effects of antiresorptive therapies on vertebral and nonvertebral fractures in postmenopausal osteoporosis

(1) Delmas, P D a,b

a UNIVERSITÉ LYON 1 (France)

b EDOUARD HERRIOT HOSPITAL (France)

Author keywords

Bisphosphonates; Calcitonin; Estrogens; Fractures; Osteoporosis; Selective estrogen receptor modulators

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; ESTROGEN RECEPTOR; RALOXIFENE; RISEDRONIC ACID; SELECTIVE ESTROGEN RECEPTOR MODULATOR; VITAMIN D;

AGED; ARTICLE; CLINICAL TRIAL; DRUG EFFECT; FEMALE; HIGH RISK POPULATION; HIP FRACTURE; HUMAN; INCIDENCE; OSTEOCLAST; OSTEOCYTE; POSTMENOPAUSE OSTEOPOROSIS; PREVENTIVE MEDICINE; RISK FACTOR; VERTEBRA FRACTURE;

BONE DENSITY; BONE RESORPTION; CONTROLLED CLINICAL TRIALS; DIPHOSPHONATES; FEMALE; FRACTURES, BONE; HUMANS; OSTEOPOROSIS, POSTMENOPAUSAL; RISK FACTORS; SPINAL FRACTURES;

EID: 0036137393 PISSN: 87563282 EISSN: None Source Type: Journal
DOI: 10.1016/S8756-3282(01)00667-6 Document Type: Article

Times cited : (37)

References (28)

1
- 0029898269
- Bone density are shape as determinants of bone strength in IGF-1 and/or pamidronate treated ovariectomized rats
- (1996) Osteopor Int , vol.6 , pp. 219-227
- Ammann, P.¹ Rizzoli, R.² Meyer, J.M.³ Bonjour, J.P.⁴

2
- 0027139913
- The effects of 2-year treatment with the amino bisphosphonate alendronate on bone metabolism, bone histomorphometry and bone strength in ovariectomized non human primates
- (1993) J Clin Invest , vol.92 , pp. 2577-2586
- Balena, R.¹ Toolan, B.C.² Shea, M.³

3
- 0004851872
- Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
- (1996) Lancet , vol.348 , pp. 1535-1541
- Black, D.M.¹ Cummings, S.R.² Karpf, D.B.³

4
- 0033755981
- Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women
- (2000) Bone , vol.27 , pp. 687-694
- Boivin, G.Y.¹ Chavassieux, P.M.² Santora, A.C.³ Yates, J.⁴ Meunier, P.J.⁵

5
- 0028860231
- Estrogen replacement therapy and fractures in older women
- (1994) Ann Intern Med , vol.122 , pp. 9-16
- Cauley, J.A.¹ Secley, D.G.² Ensrud, K.³ Ettinger, B.⁴ Black, D.⁵ Cummings, S.R.⁶

6
- 0030868816
- Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis
- (1997) J Clin Invest , vol.100 , Issue.6 , pp. 1475-1480
- Chavassieux, P.M.¹ Arlot, M.E.² Reda, C.³ Wei, L.⁴ Yates, J.A.⁵ Meunier, P.J.⁶

7
- 0033829969
- A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis; The prevent recurrence of osteoporotic fractures study
- (2000) Am J Med , vol.109 , pp. 267-276
- Chestnut, C.H.¹ Silverman, S.² Andriano, K.³ Genant, H.⁴ Gimona, A.⁵ Harris, S.⁶

8
- 0001062658
- Hormone replacement therapy
- (1999) Lancet , vol.354 , pp. 152-155

9
- 0033724685
- Pharmacological interventions for the prevention of vertebral and non vertebral fractures in women with postmenopausal osteoporosis; Does site-specificity exist?
- (2000) Bone , vol.27 , pp. 765-768
- Compston, J.¹

10
- 0032583492
- Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures. Results from the fracture intervention trial
- (1998) JAMA , vol.280 , pp. 2077-2082
- Cummings, S.R.¹ Black, D.M.² Thompson, D.E.³ Applegate, W.B.⁴ Barrett-Connor, E.⁵

11
- 0028963682
- Risk factors for hip fracture in white women
- (1995) N Engl J Med , vol.332 , pp. 767-773
- Cummings, S.R.¹ Nevitt, M.C.² Browner, W.S.³ Stone, K.⁴ Fox, K.M.⁵ Ensrud, K.E.⁶ Cauley, J.⁷ Black, D.⁸ Vogt, T.M.⁹

12
- 0030893199
- Hormone replacement therapy in the prevention and treatment of osteoporosis
- (1997) Osteopor Int , vol.7 , Issue.SUPPL. 1 , pp. 3-7
- Delmas, P.D.¹

13
- 0034080243
- How does antiresorptive therapy decrease the risk of fracture in women with osteoporosis?
- (2000) Bone , vol.27 , pp. 1-3
- Delmas, P.D.¹

14
- 0033581212
- Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene. Results from a 3 year randomized clinical trial
- (1999) JAMA , vol.282 , pp. 637-645
- Ettinger, B.¹ Black, D.M.² Mitlak, B.H.³ Knikerbocker, R.K.⁴ Nickelsen, T.⁵ Genant, H.K.⁶

15
- 17744382186
- Risedronate reverses bone loss in postmenopausal women with low bone mass; Results from a multinational, double-blind, placebo-controlled trial
- (2000) J Clin Endocrinol Metab , vol.85 , pp. 1895-1900
- Fogelman, I.¹ Ribot, C.² Smith, R.³ Ethgen, D.⁴ Sod, E.⁵ Reginster, J.Y.⁶

16
- 0028586042
- Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment
- (1994) J Clin Endocrinol Metab , vol.79 , pp. 1693-1700
- Garnero, P.¹ Shih, W.J.² Gineyts, E.³ Karpf, D.⁴ Delmas, P.D.⁵

17
- 0033552255
- Effects of risedronate treatment on vertebral and non vertebral fractures in women with postmenopausal osteoporosis
- (1999) JAMA , vol.282 , pp. 1344-1352
- Harris, S.T.¹ Watts, N.B.² Genant, H.K.³ McKeever, C.D.⁴ Thangartner, T.⁵ Keller, H.⁶

18
- 0028851590
- Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis
- (1995) N Engl J Med , vol.333 , pp. 1437-1443
- Liberman, U.A.¹ Weiss, S.R.² Broll, J.³

19
- 0035253489
- Effect of risedronate treatment on hip fracture risk in elderly women. Hip Intervention Program Study Group
- (2001) N Engl J Med , vol.344 , pp. 333-340
- McClung, M.R.¹ Geusens, P.² Miller, P.D.³ Zippel, H.⁴ Bensen, W.G.⁵

20
- 0007698676
- Radiographic vertebral deformities and stature loss as surrogate endpoints in osteoporosis treatment trials; What is the evidence
- (2000) J Bone Miner Res , vol.15 , Issue.SUPPL.
- Nevitt, M.¹ Bauer, D.² Black, D.³ Vittinghoff, E.⁴ Harris, F.⁵ Cummings, S.⁶

21
- 2042445483
- Note for Guidance on Postmenopausal Osteoporosis in Women. The European Agency for the Evaluation of Medicinal Products: Evaluation of Medicines for Human Use, CPMP/EWP/552/95 rev 1. London: EAEMP; 2001. http://www.emea.eu.int.

22
- 0033710167
- Effect of calcium or 25 OH vitamin D3 dietary supplementation on bone loss at the hip in men and women over the age of 60
- (2000) J Clin Endocrionol Metab , vol.85 , pp. 3011-3019
- Peacock, M.¹ Liu, G.² Carey, M.³ McClintock, R.⁴ Ambrosius, W.⁵ Hui, S.⁶ Johnston, C.C.⁷

23
- 0032722149
- Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin
- (1999) J Clin Invest , vol.104 , pp. 1363-1374
- Plotkin, L.I.¹ Weinstein, R.S.² Parfitt, A.M.³ Roberson, P.K.⁴ Manolagas, S.C.⁵ Bellido, T.⁶

24
- 0032896590
- Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postemenopausal women with low bone mass; Results of the FOSIT study
- (1999) Osteopor Int , vol.9 , pp. 461-468
- Pols, M.A.P.¹ Felsenberg, D.² Hanley, D.A.³ Stepan, I.⁴ Munoz-Torres, M.⁵ Wilkin, T.J.⁶

25
- 12944291524
- Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis
- (2000) Osteopor Int , vol.11 , pp. 83-91
- Reginster, J.Y.¹ Minne, H.W.² Sorensen, O.H.³

26
- 0014463475
- The relative contribution of trabecular and cortical bone to the strength of human lumbar vertebrae
- (1969) Calcif Tissue Res , vol.3 , pp. 163-175
- Rockoff, S.D.¹ Sweet, E.² Blenstein, J.³

27
- 0031856827
- The role of estrogen in the control of rat osteocyte apoptosis
- (1998) J Bone Miner Res , vol.13 , pp. 1243-1250
- Tomkinson, A.¹ Gevers, E.F.² Wit, J.M.³ Reeve, J.⁴ Noble, B.S.⁵

28
- 0033981552
- Loss of osteocyte integrity in association with microdamage and bone remodeling after fatigue in vivo
- (2000) J Bone Miner Res , vol.15 , pp. 60-67
- Verborgt, O.¹ Gibson, G.J.² Schaffler, M.B.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.